손발톱진균증의 국소치료

키워드

참고문헌 (36)

1. Schieke SM, "Fitzpatrick's dermatology in general medicine", pp.2277~2328 (2012), McGraw-Hill
2. Faergemann J, "Epidemiology, clinical presentation and diagnosis of onychomycosis", Br J Dermatol, 149(Suppl. 1), pp.1~4 (2003)
3. Cho BK, "Diagnoses and differential diagnoses of superficial mycoses", Korean J Med Mycol, 6, pp.49~56 (2001)
4. 은영선, "손발톱질환의 통계적 고찰 - 여의도성모병원 Nail Clinic, 2000∼2010 -", 대한피부과학회지, 50(1), pp.8~17 (2012), 대한피부과학회
5. Shivakumar HN, "Ungual and transungual drug delivery", Drug Dev Ind Pharm, 38, pp.901~911 (2012)
6. Gupta AK, "Antifungal agents:an overview. Part II", J Am Acad Dermatol, 30, pp.911~933 (1994)
7. Polak AM, "Preclinical data and mode of action of amorolfine", Clin Exp Dermatol, 17(Suppl. 1), pp.8~12 (1992)
8. Pittrof F, "Loceryl nail lacquer--realization of a new galenical approach to onychomycosis therapy", Clin Exp Dermatol, 17(Suppl. 1), pp.26~28 (1992)
9. Zaug M, "Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview)", Clin Exp Dermatol, 17(Suppl. 1), pp.61~70 (1992)
10. Lauharanta J, "Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly", Clin Exp Dermatol, 17(Suppl. 1), pp.41~43 (1992)
11. Reinel D, "Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly", Clin Exp Dermatol, 17(Suppl. 1), pp.44~49 (1992)
12. "The Cochrane Library: Topical treatments for fungal infections of the skin and nails of the foot", ~ (2009)
13. Del Rosso JQ, "The role of topical antifungal therapy for onychomycosis and the emergence of newer agents", J Clin Aesthet Dermatol, 7, pp.10~18 (2014)
14. Bohn M, "Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis", J Am Acad Dermatol, 43, pp.S57~S69 (2000)
15. Subissi A, "Ciclopirox : recent nonclinical and clinical data relevant to its use as a topical antimycotic agent", Drugs, 70, pp.2133~2152 (2010)
16. Gupta AK, "Therapies for the treatment of onychomycosis", Clin Dermatol, 31, pp.544~554 (2013)
17. Gupta AK, "Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States", J Am Podiatr Med Assoc, 90, pp.495~501 (2000)
18. Baran R, "An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis", J Eur Acad Dermatol Venereol, 23, pp.773~781 (2009)
19. Monti D, "Hydrosoluble medicated nail lacquers : in vitro drug permeation and corresponding antimycotic activity", Br J Dermatol, 162, pp.311~317 (2010)
20. Sigurgeirsson B, "Therapeutic potential of TDT 067(terbinafine in Transfersome) : a carrierbased dosage form of terbinafine for onychomycosis", Expert Opin Investig Drugs, 21, pp.1549~1562 (2012)
21. Tanriverdi ST, "Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis", Eur J Pharm Sci, 48, pp.628~636 (2013)
22. Dominicus R, "Openlabel study of the efficacy and safety of topical treatment with TDT 067(terbinafine in Transfersome(R))in patients with onychomycosis", Br J Dermatol, 166, pp.1360~1362 (2012)
23. Elewski BE, "Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis:results from three randomized studies using doubleblind vehicle-controlled and open-label activecontrolled designs", J Eur Acad Dermatol Venereol, 27, pp.287~294 (2013)
24. Hafeez F, "Transungual delivery of ketoconazole using novel lacquer formulation", Int J Pharm, 456, pp.357~361 (2013)
25. Lurati M, "Efficacious treatment of non-dermatophyte mould onychomycosis with topical amphotericin B", Dermatology, 223, pp.289~292 (2011)
26. Patel T, "Efinaconazole : first global approval", Drugs, 73, pp.1977~1983 (2013)
27. Tschen EH, "Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study", J Drugs Dermatol, 12, pp.186~192 (2013)
28. Tatsumi Y, "Mechanism of action of efinaconazole, a novel triazole antifungal agent", Antimicrob Agents Chemother, 57, pp.2405~2409 (2013)
29. Lipner SR, "Efinaconazole in the treatment of onychomycosis", Infect Drug Resist, 8, pp.163~172 (2015)
30. Sugiura K, "Unique pro perties of efinaconazole 10% solution, a new topical treatment for onychomycosis", Proceedings of the 71st Annual Meeting (2013), American Academy of Dermatology
31. Elewski BE, "Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies", J Am Acad Dermatol, 68, pp.600~608 (2013)
32. Elewski BE, "Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis:Results from 2 randomized phase-III studies", J Am Acad Dermatol, 73, pp.62~69 (2015)
33. Hui X, "In Vitro penetration of a novel oxaborole antifungal(AN2690)into the human nail plate", J Pharm Sci, 96, pp.2622~2631 (2007)
34. Tosti A, "Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life", J Clin Aesthet Dermatol, 7, pp.25~30 (2014)
35. Vejnovic I, "Investigation of different formulations for drug delivery through the nail plate", Int J Pharm, 386, pp.185~194 (2010)
36. 황성민, "한국인의 손발톱진균증 환자의 역학적 조사: 다기관 연구", 대한의진균학회지, 16(2), pp.35~43 (2011), 대한의진균학회[DOI]

관련 논문AI추천